| UniProt ID | LFA3_HUMAN | |
|---|---|---|
| UniProt AC | P19256 | |
| Protein Name | Lymphocyte function-associated antigen 3 | |
| Gene Name | CD58 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 250 | |
| Subcellular Localization |
Isoform 1: Cell membrane Single-pass type I membrane protein. |
|
| Protein Description | Ligand of the T-lymphocyte CD2 glycoprotein. This interaction is important in mediating thymocyte interactions with thymic epithelial cells, antigen-independent and -dependent interactions of T-lymphocytes with target cells and antigen-presenting cells and the T-lymphocyte rosetting with erythrocytes. In addition, the LFA-3/CD2 interaction may prime response by both the CD2+ and LFA-3+ cells.. | |
| Protein Sequence | MVAGSDAGRALGVLSVVCLLHCFGFISCFSQQIYGVVYGNVTFHVPSNVPLKEVLWKKQKDKVAELENSEFRAFSSFKNRVYLDTVSGSLTIYNLTSSDEDEYEMESPNITDTMKFFLYVLESLPSPTLTCALTNGSIEVQCMIPEHYNSHRGLIMYSWDCPMEQCKRNSTSIYFKMENDLPQKIQCTLSNPLFNTTSSIILTTCIPSSGHSRHRYALIPIPLAVITTCIVLYMNGILKCDRKPDRTNSN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 40 | N-linked_Glycosylation | IYGVVYGNVTFHVPS CEEEEECEEEEECCC | 16.39 | UniProtKB CARBOHYD | |
| 62 | Ubiquitination | LWKKQKDKVAELENS HHHHHHHHHHHHHCC | 50.83 | 29967540 | |
| 78 | Ubiquitination | FRAFSSFKNRVYLDT HHHHHHCCCCEEEEE | 45.88 | - | |
| 94 | N-linked_Glycosylation | SGSLTIYNLTSSDED CCEEEEEECCCCCCC | 32.75 | UniProtKB CARBOHYD | |
| 109 | N-linked_Glycosylation | EYEMESPNITDTMKF CCEECCCCHHHHHHH | 60.10 | UniProtKB CARBOHYD | |
| 135 | N-linked_Glycosylation | TLTCALTNGSIEVQC CEEEEEECCEEEEEE | 42.96 | UniProtKB CARBOHYD | |
| 169 | N-linked_Glycosylation | PMEQCKRNSTSIYFK CHHHHHHCCCEEEEE | 34.82 | 17660510 | |
| 170 | Phosphorylation | MEQCKRNSTSIYFKM HHHHHHCCCEEEEEE | 27.80 | 29978859 | |
| 171 | Phosphorylation | EQCKRNSTSIYFKME HHHHHCCCEEEEEEC | 23.77 | 29978859 | |
| 172 | Phosphorylation | QCKRNSTSIYFKMEN HHHHCCCEEEEEECC | 18.34 | 29978859 | |
| 174 | Phosphorylation | KRNSTSIYFKMENDL HHCCCEEEEEECCCC | 9.27 | 29978859 | |
| 195 | N-linked_Glycosylation | TLSNPLFNTTSSIIL EECCCCCCCCCEEEE | 50.56 | UniProtKB CARBOHYD | |
| 209 | Phosphorylation | LTTCIPSSGHSRHRY EEEECCCCCCCCCCE | 34.86 | - | |
| 247 (in isoform 3) | Phosphorylation | - | 50.83 | 20068231 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LFA3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LFA3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LFA3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| DNJA1_HUMAN | DNAJA1 | physical | 16169070 | |
| A4_HUMAN | APP | physical | 21832049 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| D02800 | Alefacept (USAN/INN); Amevive (TN) | |||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...